Money never sleeps—new capital injection is the core driver of any asset's rise. Once new capital injection stalls or withdraws, the market enters a corrective pullback. The U.S. ETF industry is experiencing unprecedented expansion: In the past two months, around 390 new ETFs were listed on the U.S. stock market, setting a record for the highest two-month addition in history. This number has more than tripled since the beginning of 2024. In other words, the number of ETFs issued in the past two months has already surpassed the total issued in the first half of 2024. Among this year's newly issued ETFs, 54% utilize derivatives, and over 33% are leveraged or inverse funds. Additionally, fund issuers have filed over 1,000 leveraged ETFs awaiting approval this year, signaling a new wave of product launches on the horizon. The ETF market is expanding at an unprecedented pace.